Synthesis of C2-symmetrical polyhydroxyazepanes as inhibitors of glycosidases
作者:Xinhua Qian、Francisco Morís-Varas、Chi-Huey Wong
DOI:10.1016/0960-894x(96)00183-7
日期:1996.5
Treatment of degenerative cartilage conditions in a mammal with Glycosidasc Inhibitors
申请人:Ichikawa Yoshitaka
公开号:US20070197471A1
公开(公告)日:2007-08-23
This invention relates to treating, preventing, and lessening the severity of conditions selected from the group consisting of osteoarthritis, rheumatoid arthritis, synovitis, subchondral bone edema, and cartilage degradation with administration of glycosidase inhibitors.
US6462193B1
申请人:——
公开号:US6462193B1
公开(公告)日:2002-10-08
[EN] HYDROXYAZEPANES AS INHIBITORS OF GLYCOSIDASE AND HIV PROTEASE<br/>[FR] HYDROXYAZEPANES SERVANT D'INHIBITEURS DE LA GLYCOSIDASE ET DE LA VIH-PROTEASE
申请人:THE SCRIPPS RESEARCH INSTITUTE
公开号:WO1998037218A1
公开(公告)日:1998-08-27
(EN) Hydroxyazepanes display inhibitory activity with respect to glycosidase, with Ki values from moderate to low micromolar range. Benzyl and 3,6-dibenzyl derivatives of hydroxyazepanes display inhibitory activity with respect to HIV protease. These compounds are synthesized either by chemoenzymatic or chemical methodologies.(FR) Les hydroxyazépanes présentent une activité inhibitrice vis-à-vis de la glycosidase, avec des valeurs de micromolarité Ki modérées à faibles. Les dérivés benzyle et 3,6-dibenzyle des hydroxyazépanes présentent une activité inhibitrice vis-à-vis de la VIH-protéase. Ces composés sont synthétisés par des méthodes chimio-enzymatiques ou chimiques.